nilla, Author at European Medical Journal - Page 19 of 20

Harnessing AI for Marketing ROI

we look at how AI tools can boost traditional marketing campaigns’ productivity, improve targeting, and deliver significant business value.

HBA's Laurie Cooke on Creating a Culture of Belonging

In what ways can we hold each other accountable, not just for the number of women in leadership, but how women, and especially women of colour, are represented and supported throughout the hiring pipeline?

The growing market of biotechnology

We consider the multi-functional uses and potential of biotechnology, highlight some of the biggest players in biotech, and forecast how the market could ascend in the coming years.

The COVID-19 vaccine race

This infographic focusses on the three front runners in the COVID-19 vaccine race, uncovering how the race unfolded, comparing the all-important efficacies and characteristics.

A Conversation on Diversity and Inclusion

We hear from three industry thought leaders who share their insights regarding the importance of championing diversity as well as their vision for pharma’s future.

The future of orphan drugs

In this infographic, we showcase the top performing orphan drug predictions for 2024 and identify the companies leading the way in this space. We also consider the six key steps for orphan drug launch success.

A decade of innovation

In this infographic, we highlight some of the biggest shifts of the pharmaceutical industry over the past decade, with increased investment and development of biologics, recombinant DNA, and gene research.

The growing pharmaceutical workforce

We showcase the predictions made for the UK biopharmaceutical workforce, highlighting where additional jobs will be needed and the number of highly skilled or specialist workers that will be required.

The history of vaccines

As pharma spearheads the search for a COVID-19 vaccine, our infographic reflects on the history of this practice, exploring the diseases and their respective vaccines.

Improving access in Africa

There are many notable initiatives in place by pharmaceutical companies to improve access to medicine around the world, especially in hard-to-reach and developing countries.